Cite
CD19 CAR T-cell therapy in relapsed TCF3-HLF-positive B-cell acute lymphoblastic leukemia.
MLA
Yao, Yao, et al. “CD19 CAR T-Cell Therapy in Relapsed TCF3-HLF-Positive B-Cell Acute Lymphoblastic Leukemia.” Annals of Hematology, Aug. 2024. EBSCOhost, https://doi.org/10.1007/s00277-024-05945-z.
APA
Yao, Y., Zhou, J., Li, Y., Shi, S., Yu, L., Wu, D., & Wang, Y. (2024). CD19 CAR T-cell therapy in relapsed TCF3-HLF-positive B-cell acute lymphoblastic leukemia. Annals of Hematology. https://doi.org/10.1007/s00277-024-05945-z
Chicago
Yao, Yao, Jin Zhou, Yanting Li, Sensen Shi, Lei Yu, Depei Wu, and Ying Wang. 2024. “CD19 CAR T-Cell Therapy in Relapsed TCF3-HLF-Positive B-Cell Acute Lymphoblastic Leukemia.” Annals of Hematology, August. doi:10.1007/s00277-024-05945-z.